arterial occlusive disease < RETINA

  • 文章类型: Journal Article
    目的:描述运动负荷试验(ET)后患者的视网膜和脉络膜血管的变化,并确定光学相干断层扫描血管造影(OCT-A)是否在预测缺血性心脏事件中发挥作用。
    方法:前瞻性比较研究,包括劳力性心绞痛患者。所有患者在进行ET之前和之后均接受OCT-A。血流量,毛细管间空间,分析了浅毛细血管丛(SCP)和深毛细血管丛(DCP)的血管密度。还分析了脉络膜毛细血管的血管密度和中央无血管区(CAZ)的参数。
    结果:在纳入研究的38只眼中,在大型SCP血管中发现39.5%的血流减少,在SCP毛细血管的50%中,在DCP中占81.6%。在68.4%的眼睛中的SCP和55.3%的DCP中观察到毛细管间隙的增加。ET后观察到DCP密度的统计学显着降低(p=0.03)。CAZ参数没有显著变化,SCP密度,也没有脉络膜的密度。ET阳性的患者DCP密度降低了83.3%。在DCP密度增加的患者中,92.85%的患者ET阴性。
    结论:这项初步研究表明,ET后DCP密度显着降低。在劳力性心绞痛患者中,DCP似乎受影响最大。需要更大的试验来进一步研究这些假设。
    OBJECTIVE: To describe retinal and choroidal vascular changes following an exercise stress test (ET) in patients with effort angina and to determine whether optical coherence tomography angiography (OCT-A) could play a role in the prediction of ischemic cardiac events.
    METHODS: Prospective comparative study including patients with effort angina. All patients underwent OCT-A before and after an ET was performed. Blood flow, intercapillary spaces, and vessel density were analyzed in the superficial capillary plexus (SCP) and the deep capillary plexus (DCP). Vessel density in the choriocapillaris and the parameters of the central avascular zone (CAZ) were also analyzed.
    RESULTS: Of the 38 eyes included in the study, a decrease in blood flow was found in 39.5% in the large SCP vessels, in 50% in the capillaris of the SCP, and in 81.6% in the DCP. An increase in intercapillary spaces was observed in the SCP in 68.4% of eyes and in the DCP in 55.3% of eyes. A statistically significant decrease in the DCP density was observed after an ET (p = 0.03). There were no significant modifications in the CAZ parameters, the SCP density, nor the choriocapillaris density. Patients with a positive ET had a decreased DCP density in 83.3%. Among patients with an increased DCP density, 92.85% had a negatif ET.
    CONCLUSIONS: This pilot study suggests that DCP density significantly decreases after an ET. The DCP appears to be most affected in patients with effort angina. A larger trial is needed to further investigate these hypotheses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    目的:报告1例因视网膜分支动脉阻塞(BRAO)引起的急性中央中央黄斑病变(PAMM)并合并COVID-19。
    方法:通过谱域光学相干断层扫描(SD-OCT)评估的病例报告,荧光素血管造影,和OCT血管造影。
    结果:一名55岁男子主诉右眼视力模糊。他出现了嗅觉缺失,并在一周前检测出COVID-19阳性。眼底检查显示视网膜有优越的颞部增白,SD-OCT显示核层上的超反射带状病变与PAMM一致。
    结论:COVID-19感染涉及炎症和血栓事件。即使只是嗅觉缺失的患者也可能有并发症,如与PAMM相关的BRAO。
    OBJECTIVE: To report a case of paracentral acute middle maculopathy (PAMM) due to branch retinal artery occlusion (BRAO) as a complication of COVID-19.
    METHODS: A case report evaluated through spectral-domain optical coherence tomography (SD-OCT), fluorescein angiography, and OCT angiography.
    RESULTS: A 55-year-old man complained of blurred vision in the right eye. He presented with anosmia and tested positive for COVID-19 one week before. Fundus examination revealed a superior temporal whitening of the retina, SD-OCT showed a hyperreflective band-like lesion on the nuclear layer consistent with PAMM.
    CONCLUSIONS: COVID-19 infection involves inflammatory and thrombotic events. Even patients with just anosmia may have complications such as BRAO associated with PAMM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:已经报道了严重急性呼吸道综合征冠状病毒2(SARS-CoV-2)疫苗接种后眼睛中的许多不良事件。这是首次报道未破裂的视网膜动脉大动脉瘤(RAM)患者在SARS-CoV-2疫苗接种(Pfizer-BioNTech的BNT162b2)后一天发生视网膜分支动脉阻塞(BRAO)。
    方法:一名具有2型糖尿病相关病史的75岁男子在接受第四剂SARS-CoV-2mRNA疫苗后1天到医院就诊,抱怨右眼突然视力下降;他的最佳矫正视力(BCVA)从1.0降至0.7(Snellen十进制)。该患者先前在同一只眼睛中被诊断为未破裂的RAM和中央上旁急性中度黄斑病变。眼底检查显示血管鞘增加。吲哚菁绿在右眼盘上显示出高荧光区域,提示RAM。荧光素血管造影和光学相干断层扫描血管造影显示视网膜上区域的动脉阻塞。
    方法:患者被诊断为BRAO伴RAM,并在没有任何额外治疗的情况下进行随访。4个月后的随访检查未显示BCVA值的任何改善。
    结论:该病例提示BRAO可能在未破裂RAM的患者接种SARS-CoV-2疫苗后发展;然而,需要更多的研究来调查原因。
    BACKGROUND: Many adverse occurrences in the eye have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. This is the first report of a patient with an unruptured retinal arterial macroaneurysm (RAM) who developed branch retinal artery occlusion (BRAO) one day after SARS-CoV-2 vaccination (BNT162b2 by Pfizer-BioNTech).
    METHODS: A 75-year-old man with a pertinent history of type-2 diabetes mellitus visited the hospital complaining of sudden visual loss in his right eye 1 day after receiving the fourth dose of the SARS-CoV-2 mRNA vaccine; his best-corrected visual acuity (BCVA) decreased from 1.0 to 0.7 (Snellen decimal). The patient had previously been diagnosed with an unruptured RAM and superior paracentral acute middle maculopathy in the same eye. Fundus examination showed increased sheathing of blood vessels. Indocyanine green showed a hyperfluorescent area suggestive of RAM on the right eye disc. Fluorescein angiography and optical coherence tomography angiography revealed arterial obstruction findings in the upper retinal area.
    METHODS: The patient was diagnosed with BRAO with RAM and was followed up without any additional treatment. Follow-up examination after 4 months did not show any improvement in BCVA value.
    CONCLUSIONS: This case suggested that BRAO could develop after SARS-CoV-2 vaccination in patients with unruptured RAM; however, more research is required to investigate the causes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号